Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Asset Utilization Ratio (2016 - 2025)

Capricor Therapeutics (CAPR) has 15 years of Asset Utilization Ratio data on record, last reported at 0.01 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 102.0% year-over-year to 0.01; the TTM value through Sep 2025 reached 0.01, down 102.0%, while the annual FY2024 figure was 0.09, 81.14% down from the prior year.
  • Asset Utilization Ratio reached 0.01 in Q3 2025 per CAPR's latest filing, down from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.74 in Q2 2024 and bottomed at 0.01 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.17, with a median of 0.03 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: soared 6015.07% in 2023, then plummeted 102.0% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2021, then soared by 811.58% to 0.05 in 2022, then skyrocketed by 893.08% to 0.53 in 2023, then crashed by 78.18% to 0.11 in 2024, then tumbled by 107.52% to 0.01 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.03 in Q1 2025.